Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for LifeRNA Holdings
- ·The full record, as it builds
Funding rounds
No funding rounds for LifeRNA Holdings are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LifeRNA Holdings
Developer of a biotech platform intended to offer innovative therapies for autoimmune and fibrotic diseases, combining scientific excellence with a mission to improve patients' lives. The company's platform combines scientific strategic development, leveraging a unique and proprietary technology and novel targeted drug delivery approaches to create transformative therapies for autoimmune and fibrotic diseases, enabling patients and their caregivers to ultimately improve their quality of life and providing hope for a healthier future.
- Sector
- Healthcare
- HQ
- Encinitas, CA, United States
- Founded
- 2024
- Website
- liferna.com/
- Ownership
- Privately Held (backing)
LifeRNA Holdings doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LifeRNA Holdings shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LifeRNA Holdings in its N-PORT filings yet. We sweep new filings monthly.